Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-09

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application for rizatriptan benzoate from Unichem Pharmaceuticals (USA), Inc., enabling the generic product to be marketed for acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)